SHL Medical

Founded in 1989, SHL Medical is a global manufacturer of drug delivery devices, producing its Molly and Maggie auto-injector platforms (Molly 1.0, Molly 2.25, Maggie 3.0, Maggie 5.0) and the Reunite connected device line. The company partners with roughly 80% of the world's top 25 pharma and biotech companies, has shipped 1.5 billion autoinjectors worldwide, and has launched more than 60 combination products across over 75 markets. Offering OEM development plus CMO and CDMO contract manufacturing, SHL Medical serves customers across North America, Europe, Asia, and Australasia from its Swiss headquarters in Zug.